Lakeland Industries (LAKE) 10-Q8 Sep 222023 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Jul. 31, 2022	Sep. 02, 2022
Cover [Abstract]
Entity Registrant Name	LAKELAND INDUSTRIES, INC.
Entity Central Index Key	0000798081
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Jul. 31, 2022
Entity Filer Category	Accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		7,514,725
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	0-15535
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	13-3115216
Entity Interactive Data Current	Yes
Entity Address Address Line 1	1525 Perimeter Parkway
Entity Address Address Line 2	Suite 325
Entity Address City Or Town	Huntsville
Entity Address State Or Province	AL
Entity Address Postal Zip Code	35806
City Area Code	256
Local Phone Number	350-3873
Security 12b Title	Common Stock
Trading Symbol	LAKE
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Net sales	$ 28,184	$ 27,466	$ 55,462	$ 61,558
Cost of goods sold	16,557	14,609	32,779	33,923
Gross profit	11,627	12,857	22,683	27,635
Operating expenses	9,832	8,791	19,440	16,939
Operating profit	1,795	4,066	3,243	10,696
Other income (expense), net	(42)	(1)	(67)	(13)
Interest expense	(13)	(4)	(22)	(5)
Income before taxes	1,740	4,061	3,154	10,678
Income tax expense	2,610	1,093	2,895	2,708
Net income (loss)	$ (870)	$ 2,968	$ 259	$ 7,970
Net income (loss) per common share:
Basic	$ (0.11)	$ 0.37	$ 0.03	$ 1
Diluted	$ (0.11)	$ 0.36	$ 0.03	$ 0.98
Weighted average common shares outstanding:
Basic	7,670,636	7,982,995	7,656,470	7,964,058
Diluted	7,670,636	8,141,107	7,841,281	8,120,409

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)
Net income (loss)	$ (870)	$ 2,968	$ 259	$ 7,970
Other comprehensive income (loss):
Foreign currency translation adjustments	(412)	(9)	(1,172)	(64)
Comprehensive income (loss)	$ (1,282)	$ 2,959	$ (913)	$ 7,906

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 41,211	$ 52,719
Accounts receivable, net of allowance for doubtful accounts of $728 and $666 at July 31, 2022 and January 31, 2022, respectively	15,891	14,771
Inventories	56,806	47,711
Prepaid VAT and other taxes	1,723	1,675
Other current assets	4,733	3,770
Total current assets	120,364	120,646
Property and equipment, net	8,388	8,714
Operating leases right-of-use assets	4,772	5,296
Deferred tax assets	2,075	2,072
Other assets	1,396	1,361
Investments	4,466	2,704
Total assets	141,461	140,793
Current liabilities
Accounts payable	8,860	5,855
Accrued compensation and benefits	2,891	3,225
Other accrued expenses	1,955	1,372
Income tax payable	515	321
Current portion of operating lease liabilities	1,013	1,242
Total current liabilities	15,234	12,015
Deferred income taxes	1,788	0
Long-term portion of operating lease liabilities	3,392	3,678
Total liabilities	20,414	15,693
Stockholders' equity
Preferred stock, $0.01 par; authorized 1,500,000 shares (none issued)	0	0
Common stock, $0.01 par; authorized 20,000,000 shares Issued 8,650,580 and 8,555,672; outstanding 7,514,725 and 7,615,967 at July 31, 2022 and January 31, 2022, respectively	87	86
Treasury stock, at cost; 1,135,855 and 939,705 shares at July 31, 2022 and January 31, 2022, respectively	17,332	14,206
Additional paid-in capital	77,811	77,826
Retained earnings	63,151	62,892
Accumulated other comprehensive loss	(2,670)	(1,498)
Total stockholders' equity	121,047	125,100
Total liabilities and stockholders' equity	$ 141,461	$ 140,793

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS
Allowance for doubtful accounts	$ 728	$ 666
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	1,500,000	1,500,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	8,650,580	8,555,672
Common stock, shares outstanding	7,514,725	7,615,967
Treasury stock, shares	1,135,855	939,705

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated other comprehensive loss
Balance, shares at Jan. 31, 2021		8,498,457	509,242
Balance, amount at Jan. 31, 2021	$ 121,751	$ 85	$ (5,023)	$ 76,781	$ 51,520	$ (1,612)
Net income	7,970	0	0	0	7,970	0
Other comprehensive loss Stock-based compensation	(64)	$ 0	0	0	0	(64)
Restricted Stock Issued, shares		43,915
Restricted Stock Issued, amount	1	$ 1	0	0	0	0
Restricted Stock Plan	608	0	0	608	0	0
Return of shares in lieu of payroll withholding	(462)	0	$ 0	(462)	0	0
Treasury stock purchased, shares			227,454
Treasury stock purchased, amount	(4,994)	$ 0	$ (4,994)	0	0	0
Balance, shares at Jul. 31, 2021		8,542,372	736,696
Balance, amount at Jul. 31, 2021	124,810	$ 86	$ (10,017)	76,927	59,490	(1,676)
Balance, shares at Apr. 30, 2021		8,542,235	509,242
Balance, amount at Apr. 30, 2021	126,574	$ 86	$ (5,023)	76,656	56,522	(1,667)
Net income	2,968	0	0	0	2,968	0
Other comprehensive loss Stock-based compensation	(9)	$ 0	0	0	0	(9)
Restricted Stock Issued, shares		137
Restricted Stock Issued, amount	0	$ 0	0	0	0	0
Restricted Stock Plan	271	0	0	271	0	0
Return of shares in lieu of payroll withholding	0	0	$ 0	0	0	0
Treasury stock purchased, shares			227,454
Treasury stock purchased, amount	(4,994)	$ 0	$ (4,994)	0	0	0
Balance, shares at Jul. 31, 2021		8,542,372	736,696
Balance, amount at Jul. 31, 2021	124,810	$ 86	$ (10,017)	76,927	59,490	(1,676)
Balance, shares at Jan. 31, 2022		8,555,672	939,705
Balance, amount at Jan. 31, 2022	125,100	$ 86	$ (14,206)	77,826	62,892	(1,498)
Net income	259	0	0	0	259	0
Other comprehensive loss Stock-based compensation	(1,172)	$ 0	0	0	0	(1,172)
Restricted Stock Issued, shares		94,908
Restricted Stock Issued, amount	1	$ 1	0	0	0	0
Restricted Stock Plan	790	0	0	790	0	0
Return of shares in lieu of payroll withholding	(805)	0	$ 0	(805)	0	0
Treasury stock purchased, shares			196,150
Treasury stock purchased, amount	(3,126)	$ 0	$ (3,126)	0	0	0
Balance, shares at Jul. 31, 2022		8,650,580	1,135,855
Balance, amount at Jul. 31, 2022	121,047	$ 87	$ (17,332)	77,811	63,151	(2,670)
Balance, shares at Apr. 30, 2022		8,635,358	964,722
Balance, amount at Apr. 30, 2022	124,792	$ 86	$ (14,612)	77,555	64,021	(2,258)
Net income	(870)	0	0	0	(870)	0
Other comprehensive loss Stock-based compensation	(412)	$ 0	0	0	0	(412)
Restricted Stock Issued, shares		15,222
Restricted Stock Issued, amount	1	$ 1	0		0	0
Restricted Stock Plan	384	0	0	384	0	0
Return of shares in lieu of payroll withholding	(128)	0	$ 0	(128)	0	0
Treasury stock purchased, shares			171,133
Treasury stock purchased, amount	(2,720)	$ 0	$ (2,720)	0	0	0
Balance, shares at Jul. 31, 2022		8,650,580	1,135,855
Balance, amount at Jul. 31, 2022	$ 121,047	$ 87	$ (17,332)	$ 77,811	$ 63,151	$ (2,670)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net income	$ 259	$ 7,970
Adjustments to reconcile net income to net cash (used in) provided by operating activities
Provision for doubtful accounts	63	21
Deferred income taxes	(1,783)	537
Depreciation and amortization	779	1,040
Stock based and restricted stock compensation	790	608
(Gain) loss on disposal of property and equipment	(4)	30
Equity in loss of equity investment	129	0
(Increase) decrease in operating assets
Accounts receivable	(1,266)	6,500
Inventories	(9,531)	(3,420)
Prepaid VAT and other taxes	(48)	(1,237)
Other assets	(1,062)	566
Increase (decrease) in operating liabilities
Accounts payable	3,013	2,655
Accrued expenses and other liabilities	517	(2,059)
Operating lease liabilities	4	(99)
Net cash (used in) provided by operating activities	(4,574)	13,112
Cash flows from investing activities:
Purchases of property and equipment	(449)	(452)
Investments	(1,891)	0
Net cash (used in) investing activities:	(2,340)	(452)
Cash flows from financing activities:
Purchase of treasury stock under stock repurchase program	(3,126)	(4,994)
Shares returned to pay employee taxes under restricted stock program	(805)	(462)
Net cash (used in) financing activities	(3,931)	(5,456)
Effect of exchange rate changes on cash and cash equivalents	(663)	39
Net increase (decrease) in cash and cash equivalents	(11,508)	7,243
Cash and cash equivalents at beginning of period	52,719	52,596
Cash and cash equivalents at end of period	41,211	59,839
Supplemental disclosure of cash flow information:
Cash paid for interest	22	5
Cash paid for taxes	1,872	2,803
Noncash investing and financing activities
Leased assets obtained in exchange for operating lease liabilities	$ 0	$ 256

Business

Business	6 Months Ended
Business	Jul. 31, 2022
Business
Business	1. Business Lakeland Industries, Inc. and Subsidiaries (“Lakeland,” the “Company,” “we,” “our” or “us”), a Delaware corporation organized in April 1986, manufacture and sell a comprehensive line of industrial protective clothing and accessories for the industrial and public protective clothing market. Our products are sold globally by our in-house sales teams, our customer service group, and authorized independent sales representatives to a network of over 1,600 global safety and industrial supply distributors. Our authorized distributors supply end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories and the utilities industry. In addition, we supply federal, state and local governmental agencies and departments, such as fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mixture of end users directly, and to industrial distributors depending on the particular country and market. Sales are made to more than 50 countries, the majority of which were into China, countries within the European Economic Community (“EEC”), Canada, Chile, Argentina, Russia, Kazakhstan, Colombia, Mexico, Ecuador, India and countries within Southeast Asia.

Basis of Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Jul. 31, 2022
Basis of Presentation
Basis of Presentation	2. Basis of Presentation The condensed consolidated financial statements of the Company are unaudited. These condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the Company's results. Intercompany accounts and transactions have been eliminated. The results reported in these condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire fiscal year ending January 31, 2023, or for any future period. The January 31, 2022, Condensed Consolidated Balance Sheet data was derived from the audited Consolidated Balance Sheet, but does not include all disclosures required by accounting principles generally accepted in the United States of America (U.S. GAAP). The accompanying condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto as of January 31, 2022 and 2021, and for each of the two years in the period ended January 31, 2022, included in our most recent annual report on Form 10-K filed on April 21, 2022. In this Form 10-Q, (a) “FY” means fiscal year; thus for example, FY23 refers to the fiscal year ending January 31, 2023, (b) “Q” refers to quarter; thus, for example, Q2 FY23 refers to the second quarter of the fiscal year ending January 31, 2023, (c) “Balance Sheet” refers to the unaudited condensed consolidated balance sheet, and (d) “Statement of Operations” refers to the unaudited condensed consolidated statement of operations.

Investments

Investments	6 Months Ended
Investments	Jul. 31, 2022
Investments
Investments	3. Investments On October 18, 2021, the Company entered into an Investment Agreement (the “Investment Agreement”) with Inova Design Solutions Ltd, a private limited company incorporated under the laws of England and Wales and headquartered in the United Kingdom, doing business as Bodytrak ® On April 28, 2022, the Company, under the terms of the Investment Agreement, acquired an additional 381,679 Series A Shares of Bodytrak for £1,500,000 ($1.9 million). After completion of the additional investment, the Company owns 18.42% of Bodytrak’s total share capital. The investment in Bodytrak is accounted for under the equity method given our board representation and the resulting ability to exercise significant influence. A substantial portion of our investment represents differences in our investment and our share of the underlying recognized net assets of Bodytrak. These differences are predominately attributable to non-amortizing intangible assets, including internally developed intellectual property, of Bodytrak. Bodytrak provides wearable monitoring solutions for customers in industrial health, safety, defense and first responder markets wanting to achieve better employee health and performance. Bodytrak’s solution is provided as a platform as a service (PaaS), delivering real-time data and cloud-based analytics, and hardware that includes a patented earpiece for physiological monitoring and audio communications. For the three and six months ended July 31, 2022, the Company recognized a loss of $102,000 and $129,000, respectively as the Company’s share of Bodytrak’s net loss. The loss is reflected in other income (expense), net in the consolidated statements of operations.

Inventories

Inventories	6 Months Ended
Inventories	Jul. 31, 2022
Inventories
Inventories	4. Inventories Inventories consist of the following (in $000s): July 31, 2022 January 31, 2022 Raw materials $ 24,912 $ 20,231 Work-in-process 996 626 Finished goods 34,409 29,910 Excess and obsolete adjustments (3,511 ) (3,056 ) $ 56,806 $ 47,711

LongTerm Debt

LongTerm Debt	6 Months Ended
LongTerm Debt	Jul. 31, 2022
LongTerm Debt
Long-Term Debt	5. Long-Term Debt Revolving Credit Facility On June 25, 2020, the Company entered into a Loan Agreement (the “Loan Agreement”) with Bank of America (“Lender”). The Loan Agreement provides the Company with a secured $12.5 million revolving credit facility, which includes a $5.0 million letter of credit sub-facility. The Company may request from time to time an increase in the revolving credit loan commitment of up to $5.0 million (for a total commitment of up to $17.5 million). Borrowing pursuant to the revolving credit facility is subject to a borrowing base amount calculated as (a) 80% of eligible accounts receivable, as defined, plus (b) 50% of the value of acceptable inventory, as defined, minus (c) certain reserves as the Lender may establish for the amount of estimated exposure, as reasonably determined by the Lender from time to time, under certain interest rate swap contracts. The borrowing base limitation only applies during periods when the Company’s quarterly funded debt to EBITDA ratio, as defined, exceeds 2.00 to 1.00. The credit facility will mature on June 25, 2025. On June 18, 2021, the Company entered into an Amendment No. 1 to Loan Agreement (the “Amendment”) with the Lender, which modifies certain terms of the Company’s existing Loan Agreement. The Amendment increases the credit limit under the Loan Agreement’s senior secured revolving credit facility from $12.5 million to $25.0 million. The Amendment also amends the covenant in the Loan Agreement that restricts acquisitions by the Company or its subsidiaries in order to allow, without the prior consent of the Lender, acquisitions of a business or its assets if there is no default under the Loan Agreement and the aggregate consideration does not exceed $7.5 million for any individual acquisition or $15.0 million on a cumulative basis for all such acquisitions. Other than the changes described above, the terms and conditions of the Loan Agreement remain in full force and effect. As of July 31, 2022, the Company had no borrowings outstanding on the letter of credit sub-facility and no borrowings outstanding under the revolving credit facility. Borrowings in UK There were no borrowings outstanding under the Company’s existing credit facility with HSBC Bank at July 31, 2022 and January 31, 2022. Amounts due to the Company, under the facility with HSBC Invoice Finance (UK) Ltd., of $0.8 million and $1.2 million as of July 31, 2022, and January 31, 2022, respectively, are included in other current assets on the accompanying consolidated balance sheets.

Concentration of Risk

Concentration of Risk	6 Months Ended
Concentration of Risk	Jul. 31, 2022
Concentration of Risk
Concentration of Risk	6. Concentration of Risk Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents, and trade receivables. Concentration of credit risk with respect to trade receivables is generally diversified due to the large number of entities comprising the Company’s customer base and their dispersion across geographic areas principally within the United States. The Company routinely addresses the financial strength of its customers and, as a consequence, believes that its receivable credit risk exposure is limited. The Company does not require customers to post collateral. The Company’s foreign financial depositories are Bank of America; China Construction Bank; Bank of China; China Industrial and Commercial Bank; HSBC (UK); Rural Credit Cooperative of Shandong; Postal Savings Bank of China; Punjab National Bank; HSBC in India, Argentina and UK; Raymond James in Argentina; TD Canada Trust; Banco Itaú S.A., Banco Credito Inversione in Chile; Banco Mercantil Del Norte SA in Mexico; ZAO KB Citibank Moscow in Russia, and JSC Bank Centercredit in Kazakhstan. The Company monitors its financial depositories by their credit rating which varies by country. In addition, cash balances in banks in the United States of America are insured by the Federal Deposit Insurance Corporation subject to certain limitations. There was approximately $4.2 million total included in the U.S. bank accounts and approximately $37.0 million total in foreign bank accounts as of July 31, 2022, of which $40.5 million was uninsured. Major Customer No customer accounted for more than 10% of net sales during the three and six month periods ended July 31, 2022 and 2021. Major Supplier No vendor accounted for more than 10% of purchases during the three and six month periods ended July 31, 2022 and 2021.

Stockholders Equity

Stockholders Equity	6 Months Ended
Stockholders Equity	Jul. 31, 2022
Stockholders Equity
Stockholders' Equity	7. Stockholders’ Equity On June 21, 2017, the stockholders of the Company approved the Lakeland Industries, Inc. 2017 Equity Incentive Plan (the “2017 Plan”). The executive officers and all other employees and directors of the Company, including its subsidiaries, are eligible to participate in the 2017 Plan. The 2017 Plan is administered by the Compensation Committee of the Board of Directors (the “Committee”), except that with respect to all non-employee directors, the Committee shall be deemed to include the full Board. The 2017 Plan provides for the grant of equity-based compensation in the form of stock options, restricted stock, restricted stock units, performance shares, performance units, or stock appreciation rights (“SARs”). On June 16, 2021, the stockholders of the Company approved Amendment No. 1 (the “Amendment”) to the 2017 Plan. The Amendment increases the number of shares of common stock, par value $0.01 per share, of the Company reserved for issuance under the Plan by 480,000 shares. An aggregate of 840,000 shares of the Company’s common stock are authorized for issuance under the 2017 Plan, as amended subject to adjustment as provided in the 2017 Plan for stock splits, dividends, distributions, recapitalizations and other similar transactions or events. If any shares subject to an award are forfeited, expire, lapse or otherwise terminate without issuance of such shares, such shares shall, to the extent of such forfeiture, expiration, lapse or termination, again be available for issuance under the 2017 Plan. The Company recognized total stock-based compensation costs, which are reflected in operating expenses (in $000’s): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2021 2021 2017 Plan: Total restricted stock and stock option programs $ 384 $ 271 $ 790 $ 608 Total income tax expense recognized for stock-based compensation arrangements $ 81 $ 70 $ 166 $ 158 Restricted Stock and Restricted Stock Units Under the 2017 Plan, as described above, the Company awarded performance-based and service-based shares of restricted stock and restricted stock units to eligible employees and directors. The following table summarizes the activity under the 2017 Plan for the six months ended July 31, 2022 and 2021. This table reflects the amount of awards granted at the number of shares that would be vested if the Company were to achieve the maximum performance level under the December 2019, April 2020, June 2021 April 2022 and June 2022 grants. Performance- Based Service-Based Total Weighted Average Grant Date Fair Value Outstanding at January 31, 2022 232,838 14,970 247,808 $ 20.89 Awarded 33,492 53,082 86,574 $ 18.17 Vested (119,164 ) (22,669) (141,833 ) Forfeited - - - Outstanding at July 31, 2022 147,166 45,383 192,549 $ 19.66 Performance- Based Service-Based Total Weighted Average Grant Date Fair Value Outstanding at January 31, 2021 245,210 30,930 276,140 $ 13.24 Awarded 23,101 38,071 61,172 $ 21.71 Vested (58,574 ) - (58,574 ) Forfeited - - - Outstanding at July 31, 2021 209,737 69,001 278,738 $ 14.75 The actual number of shares of common stock of the Company, if any, to be earned by the award recipients is determined over a three year performance measurement period based on measures that include Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) margin, revenue growth, and free cash flow for the April 2020 and June 2021 grants and revenue growth and EBITDA margin for the April 2022 grants. The performance targets have been set for each of the Minimum, Target, and Maximum levels. The actual performance amount achieved is determined by the Committee and may be adjusted for items determined to be unusual in nature or infrequent in occurrence, at the discretion of the Committee. The compensation cost is based on the fair value at the grant date, recognized over the requisite performance/service period using the straight-line method, and periodically adjusted for the probable number of shares to be awarded. As of July 31, 2022, unrecognized stock-based compensation expense totaled $2.1 million pursuant to the 2017 Plan based on outstanding awards under the 2017 Plan. This expense is expected to be recognized over approximately two years. Stock Repurchase Program On February 17, 2021, the Company’s Board of Directors approved a stock repurchase program under which the Company may On April 7, 2022, the Board of Directors authorized a new stock repurchase program under which the Company may repurchase up to $5 million of its outstanding common stock (the “New Share Repurchase Program”), effective upon the completion of the Existing Share Repurchase Program. The New Share Repurchase Program has no expiration date but may be terminated by the Board of Directors at any time. Shares repurchased in Q2 FY23 totaled 171,133 shares at a cost of $2.7 million leaving approximately $2.7 million remaining under the stock repurchase programs at July 31, 2022.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2022
Income Taxes
Income Taxes	8. Income Taxes The Company’s provision for income taxes for the three and six months ended July 31, 2022 and 2021 is based on the estimated annual effective tax rate, in addition to discrete items. The Company changed its permanent reinvestment assertions for its Chinese operations during the second quarter due to increased volatility of the Chinese yuan and an updated evaluation of investment strategies. The Company recorded $2 million in withholding taxes for a planned repatriation. Going forward, any adjustments to this provision will be reflected through current tax expense. The Company's effective tax rate for the second quarter of FY23 was 149.9%. As noted above the Company recorded $2 million in withholding taxes due to a change in its’ permanent reinvestment assertion related to China. Excluding this discrete expense, the effective rate was 35.0% which differs from the U.S. federal statutory rate of 21% primarily due to rate differentials in foreign tax jurisdictions and Global Intangible Low-Taxed Income (“GILTI”). The Company's effective tax rate for the second quarter of FY22 was 26.9% which differs from the U.S. federal statutory rate of 21% primarily due to rate differentials in foreign tax jurisdictions and state income taxes. The Company's effective tax rate for the six months ended July 31, 2022 was 91.8%. In addition to the $2 million discrete item above, in Q1 FY23, the Company recorded deferred tax benefits of $0.2 million related to accruals for China social taxes based on our evaluation of the deductibility of these items. Excluding these discrete items, the effective rate was 34.1% which differs from the U.S. federal statutory rate of 21% primarily due to rate differentials in foreign tax jurisdictions and GILTI. The Company's effective tax rate for the six months ended July 31, 2021 was 25.4% which differs from the U.S. federal statutory rate of 21% primarily due to rate differentials in foreign tax jurisdictions, state income taxes and the discrete item discussed above. The Company records net deferred tax assets to the extent the Company believes these assets will more likely than not be realized. The valuation allowance was $3.7 million and $3.2 million at July 31, 2022 and January 31, 2022, respectively.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
Net Income (Loss) Per Share	Jul. 31, 2022
Net income (loss) per common share:
Net Income (Loss) Per Share	9. Net Income (Loss) Per Share The following table sets forth the computation of basic and diluted net income (loss) per share as follows (in $000s except per share amounts): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net income (loss) $ (870 ) $ 2,968 $ 259 $ 7,970 Denominator: Denominator for basic net income (loss) per share (weighted-average shares which exclude shares in the treasury, 1,135,855 and 736,696 at July 31, 2022 and 2021, respectively 7,670,636 7,982,995 7,656,470 7,964,058 Effect of dilutive securities from restricted stock plan - 158,112 184,811 156,351 Denominator for diluted net income (loss) per share (adjusted weighted average shares) 7,670,636 8,141,107 7,841,281 8,120,409 Basic net income (loss) per share $ (0.11 ) $ 0.37 $ 0.03 $ 1.00 Diluted net income (loss) per share $ (0.11 ) $ 0.36 $ 0.03 $ 0.98

Contingencies

Contingencies	6 Months Ended
Contingencies	Jul. 31, 2022
Contingencies
Contingencies	10. Contingencies Certain conditions may exist as of the date the condensed consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been or is probable of being incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. General litigation contingencies The Company is involved in various litigation proceedings arising during the normal course of business which, in the opinion of the management of the Company, will not have a material effect on the Company’s financial position, results of operations or cash flows; however, there can be no assurance as to the ultimate outcome of these matters. As of July 31, 2022, to the best of the Company’s knowledge, there were no significant outstanding claims or litigation.

Segment Reporting

Segment Reporting	6 Months Ended
Segment Reporting	Jul. 31, 2022
Segment Reporting
Segment Reporting	11. Segment Reporting We manage our operations by evaluating each of our geographic locations. Our US operations include a facility in Alabama (primarily the distribution to customers of the bulk of our products and the light manufacturing of our chemical, woven, reflective, and fire products). The Company also maintains one manufacturing company in China (primarily disposable and chemical suit production), a manufacturing facility in Mexico (primarily disposable, reflective, fire and chemical suit production), a manufacturing facility in Vietnam (primarily disposable production) and a small manufacturing facility in India. Our China facilities produce the majority of the Company’s products and China generates a significant portion of the Company’s international revenues. We evaluate the performance of these entities based on operating profit, which is defined as income before income taxes, interest expense and other income and expenses. We have sales forces in the USA, Canada, Mexico, Europe, Latin America, India, Russia, Kazakhstan and China, which sell and distribute products shipped from the United States, Mexico, India or China. The table below represents information about reported segments for the three and six month periods noted therein: Three Months Ended July 31, Six Months Ended July 31, (in millions of dollars) (in millions of dollars) 2022 2021 2022 2021 Net Sales: USA Operations (including Corporate) $ 13.43 $ 11.30 $ 25.68 $ 27.71 Other foreign 2.43 2.55 4.62 5.01 Europe (UK) 1.88 2.69 3.85 7.09 Mexico 1.50 1.06 2.74 2.87 Asia 19.32 19.27 33.98 37.46 Canada 2.26 2.08 4.53 3.86 Latin America 2.55 3.23 4.45 6.79 Less intersegment sales (15.19 ) (14.71 ) (24.39 ) (29.23 ) Consolidated sales $ 28.18 $ 27.47 $ 55.46 $ 61.56 External Sales: USA Operations (including Corporate) $ 11.90 $ 10.16 $ 23.13 $ 25.85 Other foreign 1.83 1.75 3.64 3.33 Europe (UK) 1.88 2.69 3.85 7.09 Mexico 1.06 0.75 1.91 2.30 Asia 6.74 6.93 13.98 12.57 Canada 2.26 2.08 4.53 3.86 Latin America 2.51 3.11 4.42 6.56 Consolidated external sales $ 28.18 $ 27.47 $ 55.46 $ 61.56 Intersegment Sales: USA Operations (including Corporate) $ 1.53 $ 1.15 $ 2.55 $ 1.88 Other foreign 0.60 0.80 0.98 1.68 Mexico 0.44 0.30 0.83 0.56 Asia 12.58 12.34 20.00 24.89 Latin America 0.04 0.12 0.03 0.22 Consolidated intersegment sales $ 15.19 $ 14.71 $ 24.39 $ 29.23 Three Months Ended July 31, Six Months Ended July 31, (in millions of dollars) (in millions of dollars) 2022 2021 2022 2021 Operating Profit (Loss): USA Operations (including Corporate) $ (1.24 ) $ (1.10 ) $ (3.30 ) $ (0.83 ) Other foreign (0.07 ) 0.43 0.14 1.00 Europe (UK) (0.36 ) 0.15 (0.62 ) 1.75 Mexico (0.07 ) (0.38 ) (0.61 ) (0.33 ) Asia 3.40 3.17 5.95 6.64 Canada 0.32 0.29 0.95 0.76 Latin America 0.54 0.77 0.84 1.67 Intersegment profit (loss) (0.72 ) 0.74 (0.11 ) 0.04 Consolidated operating profit $ 1.80 $ 4.07 $ 3.24 $ 10.70 July 31, 2022 January 31, 2022 (in millions of dollars) Total Assets: USA Operations (including Corporate) $ 50.57 $ 53.36 Other foreign 8.55 8.92 Europe (UK) 7.80 8.79 Mexico 5.02 5.06 Asia 54.65 52.26 Canada 6.64 4.99 Latin America 8.23 7.41 Consolidated assets $ 141.46 $ 140.79 The table below presents external sales by product line: Three Months Ended July 31, (in millions of dollars) Six Months Ended July 31, (in millions of dollars) 2022 2021 2022 2021 External Sales by product lines: Disposables $ 12.72 $ 15.19 $ 27.22 $ 34.89 Chemical 7.16 5.60 12.27 13.86 Fire 2.98 2.52 5.67 4.42 Gloves 0.55 1.70 1.09 3.32 High Visibility 1.34 0.59 2.94 1.04 High Performance Wear 1.11 1.01 2.48 1.87 Wovens 2.32 0.86 3.79 2.16 Consolidated external sales $ 28.18 $ 27.47 $ 55.46 $ 61.56

Inventories (Tables)

Inventories (Tables)	6 Months Ended
Inventories (Tables)	Jul. 31, 2022
Inventories
Schedule of inventory	July 31, 2022 January 31, 2022 Raw materials $ 24,912 $ 20,231 Work-in-process 996 626 Finished goods 34,409 29,910 Excess and obsolete adjustments (3,511 ) (3,056 ) $ 56,806 $ 47,711

Stockholders Equity (Tables)

Stockholders Equity (Tables)	6 Months Ended
Stockholders Equity (Tables)	Jul. 31, 2022
Stockholders Equity
Schedule of share-based compensation, restricted stock units award activity	Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2021 2021 2017 Plan: Total restricted stock and stock option programs $ 384 $ 271 $ 790 $ 608 Total income tax expense recognized for stock-based compensation arrangements $ 81 $ 70 $ 166 $ 158
Schedule of stock option activity	Performance- Based Service-Based Total Weighted Average Grant Date Fair Value Outstanding at January 31, 2022 232,838 14,970 247,808 $ 20.89 Awarded 33,492 53,082 86,574 $ 18.17 Vested (119,164 ) (22,669) (141,833 ) Forfeited - - - Outstanding at July 31, 2022 147,166 45,383 192,549 $ 19.66 Performance- Based Service-Based Total Weighted Average Grant Date Fair Value Outstanding at January 31, 2021 245,210 30,930 276,140 $ 13.24 Awarded 23,101 38,071 61,172 $ 21.71 Vested (58,574 ) - (58,574 ) Forfeited - - - Outstanding at July 31, 2021 209,737 69,001 278,738 $ 14.75

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
Net Income Per Share (Tables)	Jul. 31, 2022
Net income (loss) per common share:
Schedule of earnings per share, basic and diluted	Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net income (loss) $ (870 ) $ 2,968 $ 259 $ 7,970 Denominator: Denominator for basic net income (loss) per share (weighted-average shares which exclude shares in the treasury, 1,135,855 and 736,696 at July 31, 2022 and 2021, respectively 7,670,636 7,982,995 7,656,470 7,964,058 Effect of dilutive securities from restricted stock plan - 158,112 184,811 156,351 Denominator for diluted net income (loss) per share (adjusted weighted average shares) 7,670,636 8,141,107 7,841,281 8,120,409 Basic net income (loss) per share $ (0.11 ) $ 0.37 $ 0.03 $ 1.00 Diluted net income (loss) per share $ (0.11 ) $ 0.36 $ 0.03 $ 0.98

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
Segment Reporting (Tables)	Jul. 31, 2022
Segment Reporting
Segment information	Three Months Ended July 31, Six Months Ended July 31, (in millions of dollars) (in millions of dollars) 2022 2021 2022 2021 Net Sales: USA Operations (including Corporate) $ 13.43 $ 11.30 $ 25.68 $ 27.71 Other foreign 2.43 2.55 4.62 5.01 Europe (UK) 1.88 2.69 3.85 7.09 Mexico 1.50 1.06 2.74 2.87 Asia 19.32 19.27 33.98 37.46 Canada 2.26 2.08 4.53 3.86 Latin America 2.55 3.23 4.45 6.79 Less intersegment sales (15.19 ) (14.71 ) (24.39 ) (29.23 ) Consolidated sales $ 28.18 $ 27.47 $ 55.46 $ 61.56 External Sales: USA Operations (including Corporate) $ 11.90 $ 10.16 $ 23.13 $ 25.85 Other foreign 1.83 1.75 3.64 3.33 Europe (UK) 1.88 2.69 3.85 7.09 Mexico 1.06 0.75 1.91 2.30 Asia 6.74 6.93 13.98 12.57 Canada 2.26 2.08 4.53 3.86 Latin America 2.51 3.11 4.42 6.56 Consolidated external sales $ 28.18 $ 27.47 $ 55.46 $ 61.56 Intersegment Sales: USA Operations (including Corporate) $ 1.53 $ 1.15 $ 2.55 $ 1.88 Other foreign 0.60 0.80 0.98 1.68 Mexico 0.44 0.30 0.83 0.56 Asia 12.58 12.34 20.00 24.89 Latin America 0.04 0.12 0.03 0.22 Consolidated intersegment sales $ 15.19 $ 14.71 $ 24.39 $ 29.23 Three Months Ended July 31, Six Months Ended July 31, (in millions of dollars) (in millions of dollars) 2022 2021 2022 2021 Operating Profit (Loss): USA Operations (including Corporate) $ (1.24 ) $ (1.10 ) $ (3.30 ) $ (0.83 ) Other foreign (0.07 ) 0.43 0.14 1.00 Europe (UK) (0.36 ) 0.15 (0.62 ) 1.75 Mexico (0.07 ) (0.38 ) (0.61 ) (0.33 ) Asia 3.40 3.17 5.95 6.64 Canada 0.32 0.29 0.95 0.76 Latin America 0.54 0.77 0.84 1.67 Intersegment profit (loss) (0.72 ) 0.74 (0.11 ) 0.04 Consolidated operating profit $ 1.80 $ 4.07 $ 3.24 $ 10.70 July 31, 2022 January 31, 2022 (in millions of dollars) Total Assets: USA Operations (including Corporate) $ 50.57 $ 53.36 Other foreign 8.55 8.92 Europe (UK) 7.80 8.79 Mexico 5.02 5.06 Asia 54.65 52.26 Canada 6.64 4.99 Latin America 8.23 7.41 Consolidated assets $ 141.46 $ 140.79
Schedule of revenue from external customers geographic areas	Three Months Ended July 31, (in millions of dollars) Six Months Ended July 31, (in millions of dollars) 2022 2021 2022 2021 External Sales by product lines: Disposables $ 12.72 $ 15.19 $ 27.22 $ 34.89 Chemical 7.16 5.60 12.27 13.86 Fire 2.98 2.52 5.67 4.42 Gloves 0.55 1.70 1.09 3.32 High Visibility 1.34 0.59 2.94 1.04 High Performance Wear 1.11 1.01 2.48 1.87 Wovens 2.32 0.86 3.79 2.16 Consolidated external sales $ 28.18 $ 27.47 $ 55.46 $ 61.56

Investments (Details Narrative)

Investments (Details Narrative) - Investment Agreement [Member] - Bodytrak's [Member] $ in Millions	3 Months Ended	6 Months Ended
	Jul. 31, 2022 USD ($) shares	Jul. 31, 2022 USD ($) shares
Ownership percentage	18.42%	18.42%
Recognized loss \| $	$ 10,200	$ 12,900
Payment of related party shares exchanged \| $		2.8
Current exchange rates \| $		$ 1.9
Percentages of total share capital		11.43%
Additional shares of Series A \| shares		38,167,900,000
Series A shares acquired \| shares		38,167,900,000
Convertible series A shares issued \| shares	50,890,500,000	50,890,500,000

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Inventories
Raw materials	$ 24,912	$ 20,231
Work-in-process	996	626
Finished goods	34,409	29,910
Excess and obsolete reserves	(3,511)	(3,056)
Inventories, net	$ 56,806	$ 47,711

LongTerm Debt (Details Narrativ

LongTerm Debt (Details Narrative) - USD ($) $ in Thousands	1 Months Ended		6 Months Ended
LongTerm Debt (Details Narrative) - USD ($) $ in Thousands	Jun. 18, 2021	Jun. 25, 2020	Jul. 31, 2022	Jan. 31, 2022
HSBC Bank [Member]
Due amount			$ 800	$ 120
Loan Agreement \| Bank Of America
Revolving credit facility	$ 12,500	$ 12,500
Warranties to the Lender in the Loan Agreement		The Company may request from time to time an increase in the revolving credit loan commitment of up to $5.0 million (for a total commitment of up to $17.5 million). Borrowing pursuant to the revolving credit facility is subject to a borrowing base amount calculated as (a) 80% of eligible accounts receivable, as defined, plus (b) 50% of the value of acceptable inventory, as defined, minus (c) certain reserves as the Lender may establish for the amount of estimated exposure, as reasonably determined by the Lender from time to time, under certain interest rate swap contracts.
Credit sub facility	25,000		$ 5,000
Aggregate consideration	7,500
Individual acquisitions amount	$ 15,000
Credit facility mature date			Jun. 25, 2025

Concentration of Risk (Details

Concentration of Risk (Details Narrative) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash balances in banks in the United States of America	$ 4.2
Cash balances in foreign bank accounts	37
Uninsured amount	$ 40.5
Major Customer [Member]
Concentration risk of net sales	10%	10%
Major Supplier [Member]
Concentration risk of net sales	10%	10%

Stockholders Equity (Details)

Stockholders Equity (Details) - 2017 Plan [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Total restricted stock and stock option programs	$ 384	$ 271	$ 608	$ 790
Total income tax benefit recognized for stock-based compensation arrangements	$ 81	$ 70	$ 158	$ 166

Stockholders Equity (Details 1)

Stockholders Equity (Details 1) - $ / shares	3 Months Ended	6 Months Ended
Stockholders Equity (Details 1) - $ / shares	Apr. 30, 2021	Jul. 31, 2022
Total [Member]
Outstanding at January 31	276,140	247,808
Vested	(58,574)	(141,833)
Awarded	61,172	86,574
Outstanding at April 30	278,738	192,549
Weighted Average Grant Date Fair Value [Member]
Outstanding at January 31	$ 13.24	$ 20.89
Weighted average awarded rate	21.71	18.17
Outstanding at April 30	$ 14.75	$ 19.66
Performance Based [Member]
Outstanding at January 31	245,210	232,838
Vested	(58,574)	(119,164)
Awarded	23,101	33,492
Outstanding at April 30	209,737	147,166
Service Based [Member]
Outstanding at January 31	30,930	14,970
Awarded	38,071	53,082
Outstanding at April 30	69,001	45,383
Vested		(22,669)

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended		6 Months Ended
	Apr. 07, 2022	Jul. 06, 2021	Jun. 16, 2021	Feb. 17, 2021	Jul. 31, 2022	Jan. 31, 2022
Common stock, shares authorized					20,000,000	20,000,000
2017 Plan [Member]
Common stock, shares authorized					840,000
Stock Repurchase Program [Member]
Remaining value of repurchase of outstanding common stock				$ 5,000	$ 2,700
Price per share			$ 0.01
Additional shares of common oitstanding		5,000,000
Repurchase of outstanding common stock	5,000,000		480,000		171,133
Repurchase of outstanding common stock, amount					$ 2,700
Other Compensation Plans/Programs [Member]
Unrecognized stock-based compensation expense					$ 210

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended		12 Months Ended
Income Taxes (Details Narrative) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Change in valuation allowance		$ 3,700		$ 3,200
Withholding taxes		2,000
Deferred tax benefits		(1,783)	$ 537
2023 Plan [Member]
Withholding taxes	$ 2,000
Effective tax rates	35%
Tax rate	21%
Federal tax statutory rate	149.90%
2022 Plan [Member]
Tax rate	21%
Federal tax statutory rate	26.90%
China Social Taxes [Member]
Deferred tax benefits	$ 2,000	$ 200
Effective tax rates	34.10%	91.80%	25.40%
Tax rate		21%	21%

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Net income (loss) per common share:
Net income	$ (870)	$ 2,968	$ 259	$ 7,970
Denominator for basic net income (loss) per share (weighted-average shares which exclude shares in the treasury, 1,133,097 and 736,696 at July 31, 2022 and 2021, respectively	7,670,636	7,982,995	7,656,470	7,964,058
Effect of dilutive securities from restricted stock plan and from dilutive effect of stock options		158,112	184,811	156,351
Denominator for diluted net income per share (adjusted weighted average shares)	7,670,636	8,141,107	7,841,281	8,120,409
Basic net income per share	$ (0.11)	$ 0.37	$ 0.03	$ 1
Diluted net income per share	$ (0.11)	$ 0.36	$ 0.03	$ 0.98

Segment Reporting (Details)

Segment Reporting (Details) - USD ($)	3 Months Ended		6 Months Ended
Segment Reporting (Details) - USD ($)	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Apr. 30, 2022	Jan. 31, 2022
External sales	$ 28,180,000	$ 27,470,000	$ 55,460,000	$ 61,560,000
Total [Member]
Net sales	28,180,000	27,470,000	55,460,000	61,560,000
External sales	28,180,000	27,470,000	55,460,000	61,560,000
Intersegment sales	15,190,000	14,710,000	24,390,000	29,230,000
Operating profit	18,000	40,700	32,400	107,000
Total assets less intersegment					$ 141,460,000	$ 140,790,000
USA [Member]
Net sales	13,430,000	11,300,000	25,680,000	27,710,000
External sales	11,900,000	10,160,000	23,130,000	25,850,000
Intersegment sales	1,530,000	1,150,000	2,550,000	1,880,000
Operating profit	(12,400)	(11,000)	(33,000)	8,300
Total assets less intersegment					50,570,000	53,360,000
Other Foreign [Member]
Net sales	2,430,000	2,550,000	4,620,000	5,010,000
External sales	1,830,000	1,750,000	3,640,000	3,330,000
Intersegment sales	600,000	800,000	980,000	1,680,000
Operating profit	700	4,300	1,400	10,000
Total assets less intersegment					8,550,000	8,920,000
Europe (UK) [Member]
Net sales	1,880,000	2,690,000	3,850,000	7,090,000
External sales	1,880,000	2,690,000	3,850,000	7,090,000
Operating profit	(3,600)	1,500	(6,200)	17,500
Total assets less intersegment					7,800,000	8,790,000
Mexico [Member]
Net sales	1,500,000	1,060,000	2,740,000	2,870,000
External sales	1,060,000	750,000	1,910,000	2,300,000
Intersegment sales	440,000	300,000	830,000	560,000
Operating profit	(700)	(3,800)	(6,100)	(3,300)
Total assets less intersegment					5,020,000	5,060,000
Asia [Member]
Net sales	19,320,000	19,270,000	33,980,000	37,460,000
External sales	6,740,000	6,930,000	13,980,000	12,570,000
Intersegment sales	12,580,000	12,340,000	20,000,000	24,890,000
Operating profit	34,000	31,700	59,500	66,400
Total assets less intersegment					54,650,000	52,260,000
Canada [Member]
Net sales	2,260,000	2,080,000	4,530,000	3,860,000
External sales	2,260,000	2,080,000	4,530,000	3,860,000
Operating profit	3,200	2,900	9,500	7,600
Total assets less intersegment					6,640,000	4,990,000
Latin America [Member]
Net sales	2,550,000	3,230,000	4,450,000	6,790,000
External sales	2,510,000	3,110,000	4,420,000	6,560,000
Intersegment sales	40,000	120,000	30,000	220,000
Operating profit	5,400	7,700	8,400	16,700
Total assets less intersegment					$ 8,230,000	$ 7,410,000
Intersegment [Member]
Net sales	(15,190,000)	(14,710,000)	(24,390,000)	(29,230,000)
Operating profit	$ (7,200)	$ 7,400	$ (1,100)	$ 400

Segment Reporting (Details 1)

Segment Reporting (Details 1) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Segment Reporting (Details 1) - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
External sales	$ 28,180	$ 27,470	$ 55,460	$ 61,560
Chemical [Member]
External sales	7,160	5,600	12,270	13,860
Fire [Member]
External sales	2,980	2,520	5,670	4,420
Disposables [Member]
External sales	12,720	15,190	27,220	34,890
Gloves [Member]
External sales	550	1,700	1,090	3,320
High Visibility [Member]
External sales	1,340	590	2,940	1,040
High Performance Wear [Member]
External sales	1,110	1,010	2,480	1,870
Wovens [Member]
External sales	$ 2,320	$ 860	$ 3,790	$ 2,160